CLINICAL STUDY: LEFT VENTRICULAR HYPERTROPHY IN ATHLETES
Physiologic limits of left ventricular hypertrophy in elite junior athletes
Relevance to differential diagnosis of athletes heart and hypertrophic cardiomyopathy
Sanjay Sharma, MD* ,*,
Barry J. Maron, MD ,
Greg Whyte, PhD ,
Sami Firoozi, MD ,
Perry M. Elliott, MD and
William J. McKenna, MD
* Department of Cardiology, University Hospital Lewisham, London, United Kingdom
Department of Cardiological Sciences, St Georges Hospital Medical School, Cranmer Terrace, London, United Kingdom
Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
University of Wolverhampton, Division of Sports Studies, Walsall Campus, Walsall, United Kingdom
Manuscript received November 5, 2001;
revised manuscript received June 3, 2002,
accepted July 2, 2002.
* Reprint requests and correspondence: Dr. Sanjay Sharma, Department of Cardiology, University Hospital Lewisham, Lewisham High Street, London SE13 6LH, United Kingdom.
OBJECTIVES: The present study was undertaken to define physiologic limits of left ventricular hypertrophy in elite adolescent athletes.
BACKGROUND: Systematic sports training may cause increased left ventricular wall thickness (LVWT), creating uncertainty regarding the differential diagnosis of athletes heart from hypertrophic cardiomyopathy (HCM). This distinction is crucial because HCM is responsible for about one-third of all sudden deaths in young athletes. Echocardiographic data defining athletes heart are limited largely to adults, with little information specifically in adolescent athletes (14 to 18 years old), for whom the risk of sudden death from HCM is highest.
METHODS: Seven hundred and twenty elite adolescent athletes (75% male) aged 15.7 ± 1.4 years participating in ball, racket, and endurance sports and 250 healthy sedentary controls of similar age, gender, and body surface area underwent echocardiography.
RESULTS: Compared with controls, athletes had greater absolute LVWT (9.5 ± 1.7 mm vs. 8.4 ± 1.4 mm; p < 0.0001). Maximal LVWT exceeded predicted upper limits in 38 athletes (5%); however, no female athlete had a LVWT >11 mm and only three trained male athletes had absolute LVWT >12 mm (0.4%). Each of the 38 athletes with a LVWT exceeding predicted limits also showed enlarged left ventricular cavity dimension (54.4 ± 2.1 mm; range 52 to 60 mm).
CONCLUSIONS: Trained adolescent athletes demonstrated greater absolute LVWT compared with nonathletes. Only a small proportion of athletes exhibited a LVWT exceeding upper limits, very rarely >12 mm, and then always with chamber enlargement. Hypertrophic cardiomyopathy should be considered strongly in any trained adolescent male athlete with LVWT >12 mm (females >11 mm) and nondilated left ventricle.
|
Abbreviations and Acronyms
| | HCM | | hypertrophic cardiomyopathy | | h/R | | relative wall thickness | | LV | | left ventricular | | LVH | | left ventricular hypertrophy | | LVWT | | left ventricular wall thickness | | 2D | | two-dimensional |
|
This article has been cited by other articles:

|
 |

|
 |
 
S. Gupta, T. Baman, and S. M. Day
Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening
Sports Health: A Multidisciplinary Approach,
November 1, 2009;
1(6):
500 - 507.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B J Maron
Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening
Br. J. Sports Med.,
September 1, 2009;
43(9):
649 - 656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Papadakis, S. Basavarajaiah, J. Rawlins, C. Edwards, J. Makan, S. Firoozi, L. Carby, and S. Sharma
Prevalence and significance of T-wave inversions in predominantly Caucasian adolescent athletes
Eur. Heart J.,
July 2, 2009;
30(14):
1728 - 1735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rawlins, A. Bhan, and S. Sharma
Left ventricular hypertrophy in athletes
Eur J Echocardiogr,
May 1, 2009;
10(3):
350 - 356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Bernhardt
Standards for LVH in Elite Athletes
AAP Grand Rounds,
December 1, 2008;
20(6):
65 - 65.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Y Khamis and J. Mayet
Echocardiographic assessment of left ventricular hypertrophy in elite athletes
Heart,
October 1, 2008;
94(10):
1254 - 1255.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Basavarajaiah, A. Boraita, G. Whyte, M. Wilson, L. Carby, A. Shah, and S. Sharma
Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy.
J. Am. Coll. Cardiol.,
June 10, 2008;
51(23):
2256 - 2262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. E. Dewey, D. Rosenthal, D. J. Murphy Jr, V. F. Froelicher, and E. A. Ashley
Does Size Matter?: Clinical Applications of Scaling Cardiac Size and Function for Body Size
Circulation,
April 29, 2008;
117(17):
2279 - 2287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Baggish, F. Wang, R. B. Weiner, J. M. Elinoff, F. Tournoux, A. Boland, M. H. Picard, A. M. Hutter Jr., and M. J. Wood
Training-specific changes in cardiac structure and function: a prospective and longitudinal assessment of competitive athletes
J Appl Physiol,
April 1, 2008;
104(4):
1121 - 1128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Basavarajaiah, M. Wilson, G. Whyte, A. Shah, W. McKenna, and S. Sharma
Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
J. Am. Coll. Cardiol.,
March 11, 2008;
51(10):
1033 - 1039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Faber and F. van Buuren
Athlete screening for occult cardiac disease: no risk, no fun?
J. Am. Coll. Cardiol.,
March 11, 2008;
51(10):
1040 - 1041.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. De Mozzi, U. G. Longo, G. Galanti, and N. Maffulli
Bicuspid aortic valve: a literature review and its impact on sport activity
Br. Med. Bull.,
March 1, 2008;
85(1):
63 - 85.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Basavarajaiah, M. Wilson, R. Naghavi, G. Whyte, M. Turner, and S. Sharma
Physiological upper limits of left ventricular dimensions in highly trained junior tennis players
Br. J. Sports Med.,
November 1, 2007;
41(11):
784 - 788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. F. Nagueh and J. J. Mahmarian
Noninvasive Cardiac Imaging in Patients With Hypertrophic Cardiomyopathy
J. Am. Coll. Cardiol.,
December 19, 2006;
48(12):
2410 - 2422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Maron and A. Pelliccia
The Heart of Trained Athletes: Cardiac Remodeling and the Risks of Sports, Including Sudden Death
Circulation,
October 10, 2006;
114(15):
1633 - 1644.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Ashley, A. Kardos, E. S. Jack, W. Habenbacher, M. Wheeler, Y. M. Kim, J. Froning, J. Myers, G. Whyte, V. Froelicher, et al.
Angiotensin-Converting Enzyme Genotype Predicts Cardiac and Autonomic Responses to Prolonged Exercise
J. Am. Coll. Cardiol.,
August 1, 2006;
48(3):
523 - 531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Basavarajaiah, M Wilson, S Junagde, G Jackson, G Whyte, S Sharma, and W O Roberts
Physiological left ventricular hypertrophy or hypertrophic cardiomyopathy in an elite adolescent athlete: role of detraining in resolving the clinical dilemma * Commentary
Br. J. Sports Med.,
August 1, 2006;
40(8):
727 - 729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pelliccia and B. J. Maron
Reply
J. Am. Coll. Cardiol.,
June 6, 2006;
47(11):
2342 - 2342.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Basavarajaiah, J. Makan, S.H. R. Naghavi, G. Whyte, S. Gati, and S. Sharma
Physiological Upper Limits of Left Atrial Diameter in Highly Trained Adolescent Athletes
J. Am. Coll. Cardiol.,
June 6, 2006;
47(11):
2341 - 2342.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Fagard
Athlete's heart
Heart,
December 1, 2003;
89(12):
1455 - 1461.
[Full Text]
[PDF]
|
 |
|
|